The largest community of pharma leaders

COVAXX Announces Emergency Use Authorization (EUA) of UBI SARS-CoV-2 ELISA Antibody Test for COVID-19

NEW YORK–(BUSINESS WIRE)– #Covid19–COVAXX announces receipt of FDA Emergency Use Authorization (EUA) for its COVID-19 antibody test, valued for its ability to identify antibody levels.

Source Business Wire Health: Pharmaceutical NewsRead More

Recent Articles